108
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Factors associated with and impact of pain persistence in Asian patients with depression: a 3-month, prospective observational study

, , , &
Pages 29-35 | Received 06 Feb 2015, Accepted 22 Aug 2016, Published online: 26 Oct 2016

References

  • American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders text revision: DSM-IV-TR. Washington DC: American Psychiatric Press.
  • Ang QQ, Wing YK, He Y, Sulaiman AH, Chiu NY, Shen YC, Wang G, Zhang C, Lee KH, Singh P, et al. 2009. Association between painful physical symptoms and clinical outcomes in East Asian patients with major depressive disorder: a 3-month prospective observational study. Int J Clin Pract. 63:1041–1049.
  • Bahk WM, Park S, Jon DI, Yoon BH, Min KJ, Hong JP. 2011. Relationship between painful physical symptoms and severity of depressive symptomatology and suicidality. Psychiatry Res. 189:357–367.
  • Bair MJ, Robinson RL, Katon W, Kroenke K. 2003. Depression and pain comorbidity: a literature review. Arch Intern Med. 163:2433–2445.
  • Bair MJ, Robinson RL, Eckert GJ, Stang PE, Croghan TW, Kroenke K. 2004. Impact of pain on depression treatment response in primary care. Psychosom Med. 66:17–22.
  • Basbaum AI, Fields HL. 1978. Endogenous pain control mechanisms: review and hypothesis. Ann Neurol. 4:451–462.
  • Brooks R, Rabin R, de Charro F. 2003. The measurement and valuation of health status using EQ-5D: a European perspective. Dordrecht, The Netherlands: Kluwer Academic Publishers.
  • Burt VK. 2004. Plotting the course to remission: the search for better outcomes in the treatment of depression. J Clin Psychiatry. 65(Suppl 12):20–25.
  • Chen C, Si TM, Xiang YT, Ungvari GS, Wang CY, He YL, Kua EH, Fujii S, Sim K, Trivedi JK, et al. 2015. Prevalence and prescription of antidepressants in depression with somatic comorbidity in Asia: the Research on East Asian Psychotropic Prescription Patterns study. Chin Med J. 128:853–858.
  • Corruble E, Guelfi JD. 2000. Pain complaints in depressed inpatients. Psychopathology. 33:307–309.
  • de Heer EW, Gerrits MM, Beekman AT, Dekker J, van Marwijk HW, de Waal MW, Spinhoven P, Penninx BW, van der Feltz-Cornelis CM. 2014. The association of depression and anxiety with pain: a study from NESDA. PLoS One. 9:e106907.
  • DeVeaugh-Geiss AM, West SL, Miller WC, Sleath B, Gaynes BN, Kroenke K. 2010. The adverse effects of comorbid pain on depression outcomes in primary care patients: results from the ARTIST trial. Pain Med. 11:732–741.
  • Doraiswamy PM, Khan ZM, Donahue RM, Richard NE. 2001. Quality of life in geriatric depression: a comparison of remitters, partial responders, and nonresponders. Am J Geriatr Psychiatry. 9:423–428.
  • EuroQoL Group. 1990. EuroQoL − a new facility for the measurement of health-related quality of life. Health Policy. 16:199–208.
  • Fu AZ, Kattan MW. 2006. Racial and ethnic differences in preference-based health status measure. Curr Med Res Opin. 22:2439–2448.
  • Geerlings SW, Twisk JW, Beekman AT, Deeg DJ, van Tilburg W. 2002. Longitudinal relationship between pain and depression in older adults: sex, age and physical disability. Soc Psychiatry Psychiatr Epidemiol. 37:23–30.
  • Gerhards SA, Huibers MJ, Theunissen KA, de Graaf LE, Widdershoven GA, Evers SM. 2011. The responsiveness of quality of life utilities to change in depression: a comparison of instruments (SF-6D, EQ-5D, and DFD). Value Health. 14:732–739.
  • Gerrits MM, van Marwijk HW, van Oppen P, van der Horst H, Penninx BW. 2014. Longitudinal association between pain, and depression and anxiety over four years. J Psychosom Res. 78:64–70.
  • Greco T, Eckert G, Kroenke K. 2004. The outcome of physical symptoms with treatment of depression. J Gen Intern Med. 19:813–818.
  • Grover S, Kumar V, Chakrabarti S, Hollikatti P, Singh P, Tyagi S, Kulhara P, Avasthi A. 2012. Prevalence and type of functional somatic complaints in patients with first-episode depression. East Asian Arch Psychiatry. 22:146–153.
  • Günther OH, Roick C, Angermeyer MC, König HH. 2008. The responsiveness of EQ-5D utility scores in patients with depression: a comparison with instruments measuring quality of life, psychopathology and social functioning. J Affect Disord. 105:81–91.
  • Gureje O, Simon GE, Von Korff M. 2001. A cross-national study of the course of persistent pain in primary care. Pain. 92:195–200.
  • Guy W. 1976. ECDEU Assessment Manual for Psychopharmacology, Revised. Bethesda, MD: US Department of Health, Education and Welfare.
  • Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:56–62.
  • Hilderink PH, Burger H, Deeg DJ, Beekman AT, Oude Voshaar RC. 2012. The temporal relation between pain and depression: results from the longitudinal aging study Amsterdam. Psychosom. 74:945–951.
  • Hong J, Novick D, Montgomery W, Moneta MV, Dueñas H, Peng X, Haro JM. 2016. Real-world outcomes in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia. Asia Pac Psychiatry. 8:51–9.
  • Hung C-I, Weng L-J, Su Y-J, Liu CY. 2006. Depression and somatic symptoms scale: a new scale with both depression and somatic symptoms emphasized. Psychiatry Clin Neurosci. 60:700–708.
  • Johnson JA, Luo N, Shaw JW, Kind P, Coons SJ. 2005. Valuations of EQ-5D health states: are the United States and United Kingdom different? Med Care. 43:221–228.
  • Kapfhammer H-P. 2006. Somatic symptoms in depression. Dialogues Clin Neurosci. 8:227–239.
  • Karp JF, Scott J, Houck P, Reynolds CF 3rd, Kupfer DJ, Frank E. 2005. Pain predicts longer time to remission during treatment of recurrent depression. J Clin Psychiatry. 66:591–597.
  • Kirmayer LJ, Robbins JM, Dworking M, Yaffe MJ. 1993. Somatization and the recognition of depression and anxiety in primary care. Am J Psychiatry. 150:734–741.
  • Kroenke K, Spitzer RL, Williams JB, Linzer M, Hahn SR, de Gruy FV 3rd, Brody D. 1994. Physical symptoms in primary care. Predictors of psychiatric disorders and functional impairment. Arch Fam Med. 3:774–779.
  • Kroenke K, Wu J, Bair MJ, Krebs EE, Damush TM, Tu W. 2011. Reciprocal relationship between pain and depression: a 12-month longitudinal analysis in primary care. J Pain. 12:964–973.
  • Lee P, Zhang M, Hong JP, Chua HC, Chen KP, Tang SW, Chan BT, Lee MS, Lee B, Gallagher GL, Dossenbach M. 2009. Frequency of painful physical symptoms with major depressive disorder in Asia: relationship with disease severity and quality of life. J Clin Psychiatry. 70:83–91.
  • Muñoz RA, McBride ME, Brnabic AJ, López CJ, Hetem LA, Secin R, Dueñas HJ. 2005. Major depressive disorder in Latin America: the relationship between depression severity, painful somatic symptoms, and quality of life. J Affect Disord. 86:93–98.
  • Norman R, Cronin P, Viney R, King M, Street D, Ratcliffe J. 2013. International comparisons in valuing EQ-5D health states: a review and analysis. Value Health. 12:1194–1200.
  • Novick D, Montgomery W, Aguado J, Kadziola Z, Peng X, Brugnoli R, Haro JM. 2013. Which somatic symptoms are associated with an unfavorable course in Asian patients with major depressive disorder? J Affect Disord. 149:182–188.
  • Novick D, Montgomery W, Moneta MV, Peng X, Brugnoli R, Haro JM. 2015. Chinese patients with major depression: do concomitant pain symptoms affect quality of life independently of severity of depression? Int J Psychiatry Clin Pract. 7:1–8.
  • Paykel ES, Scott J, Teasdale JD, Johnson AL, Garland A, Moore R, Jenaway A, Cornwall PL, Hayhurst H, Abbott R, Pope M. 1999. Prevention of relapse in residual depression by cognitive therapy: a controlled trial. Arch Gen Psychiatry. 56:829–835.
  • Rabin R, de Charro F. 2001. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 33:337–343.
  • Sapin C, Fantino B, Nowicki M-L, Kind P. 2004. Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorder. Health Qual Life Outcomes. 2:20.
  • Simon GE, von Korff M, Lin E. 2005. Clinical and functional outcomes of depression treatment in patients with and without chronic medical illness. Psychol Med. 35:271–279.
  • Sobocki P, Ekman M, Agren H, Krakau I, Runeson B, Mårtensson B, Jönsson B. 2007. Health-related quality of life measured with EQ-5D in patients treated for depression in primary care. Value Health. 10:153–160.
  • Stahl SM. 2002. The psychopharmacology of painful physical symptoms in depression. J Clin Psychiatry. 63:5.
  • Trivedi MH. 2004. The link between depression and physical symptoms. Prim Care Companion J Clin Psychiatry. 6(Suppl 1):12–16.
  • Walters SJ, Brazier JE. 2005. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res. 14:1523–1532.
  • Wang HM, Patrick DL, Edwards TC, Shalicky AM, Zeng HY, Gu WW. 2012. Validation of the EQ-5D in a general population sample in urban China. Qual Life Res. 21:155–160.
  • Williams LS, Jones WJ, Shen J, Robinson RL, Kroenke K. 2004. Outcomes of newly referred neurology outpatients with depression and pain. Neurology. 63:674–677.
  • Williams LJ, Jacka FN, Pascoe JA, Dodd S, Berk M. 2006. Depression and pain: an overview. Acta Neuropsychiatrica. 18:79–87.
  • World Health Organization. 2007. International Classification of Diseases and Related World Health Problems. Geneva: WHO.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.